New guidelines now recommend genetic testing to determine hereditary risk for all breast cancer patients. To ensure ease of use and reduce turn-around time in laboratory setting, Paragon Genomics offers CleanPlex® Hereditary Cancer Panel, an amplicon-based NGS assay that can be performed in just 3 hours, allowing next-day report generation.
|